ALS Association Drafting Drug Development Guidance; Learning From DMD Advocacy
This article was originally published in RPM Report
Executive Summary
A Lou Gehrig’s disease patient advocacy group is moving forward with a drug development guidance of its own to the jumpstart the regulatory approval process.